Co-Diagnostics, Inc. (CODX) — 10-Q Filings

10-Q Filings (6)

• CODX Revenue Plummets 90% Amid Going Concern Doubts — Nov 13, 2025 Risk: high
  Co-Diagnostics, Inc. (CODX) experienced a significant decline in revenue and increased net losses for the nine months ended September 30, 2025, compared to the
• CODX Revenue Plummets Amid Grant Loss, Going Concern Doubts Emerge — Aug 14, 2025 Risk: high
  Co-Diagnostics, Inc. (CODX) reported a significant decline in total revenue for the six months ended June 30, 2025, dropping to $213,187 from $3,124,694 in the
• Co-Diagnostics Q1 Revenue Declines — May 8, 2025 Risk: medium
  Co-Diagnostics, Inc. filed its 10-Q for the period ending March 31, 2025. The company reported product revenue of $1.75 million for Q1 2025, a decrease from $2.
• Co-Diagnostics Q3 2024 10-Q Filed — Nov 7, 2024 Risk: medium
  Co-Diagnostics, Inc. filed its 10-Q for the period ending September 30, 2024. The filing details financial performance and operational updates for the third qua
• Co-Diagnostics Q2 Revenue Declines — Aug 8, 2024 Risk: medium
  Co-Diagnostics, Inc. filed its 10-Q for the period ending June 30, 2024. The company reported product revenue of $2.04 million for the second quarter of 2024, a
• Co-Diagnostics, Inc. Files 10-Q for Period Ending March 31, 2024 — May 9, 2024 Risk: medium
  Co-Diagnostics, Inc. (CODX) filed a Quarterly Report (10-Q) with the SEC on May 9, 2024. Co-Diagnostics, Inc. filed a 10-Q report for the period ending March 31

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX